Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[CA 15-3 and breast cancer]

E Antoine1, L Kayitalire, M Spielmann

  • 1Institut Gustave-Roussy, Villejuif, France.

La Revue De Medecine Interne
|January 1, 1994
PubMed
Summary

The CA 15-3 antigen is not useful for early breast cancer screening but excels at detecting recurrence. A rise in CA 15-3 levels often precedes clinical recurrence by several months.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes.

Clinical genetics·2017
Same author

Microduplications encompassing the Sonic hedgehog limb enhancer ZRS are associated with Haas-type polysyndactyly and Laurin-Sandrow syndrome.

Clinical genetics·2014
Same author

The Liebenberg syndrome: in depth analysis of the original family.

The Journal of hand surgery, European volume·2013
Same author

Frequency of symptomatic zinc deficiency in very low birth weight infants.

Klinische Padiatrie·2012
Same author

FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Area of Science:

  • Oncology
  • Biomarkers
  • Tumor Markers

Context:

  • CA 15-3 antigen's role in breast cancer management is under investigation.
  • Current understanding suggests limited utility in screening and initial prognosis.
  • Focus is on its potential for recurrence detection and monitoring.

Purpose:

  • To evaluate the clinical significance of CA 15-3 antigen in breast cancer.
  • To assess its efficacy in early recurrence detection and disease monitoring.
  • To clarify its role in managing suspected biological recurrence.

Summary:

  • CA 15-3 antigen lacks value in early breast cancer screening and independent prognostic capability.
  • It demonstrates significant utility in the early detection of first recurrences, particularly for bone, liver, and lung metastases.
  • A rise in CA 15-3 levels can precede clinical or radiological diagnosis of recurrence by 6-9 months, showing higher sensitivity and specificity than CEA.
  • CA 15-3 serves as a reliable marker for disease course and shows potential in monitoring therapeutic response.

Impact:

  • Provides insights into the optimal use of CA 15-3 in breast cancer follow-up.
  • Highlights the need for prospective trials to define diagnostic and therapeutic strategies for isolated CA 15-3 elevations.
  • Aims to improve patient management by clarifying the role of this tumor marker in recurrence detection and therapy monitoring.

Related Experiment Videos